2023 Form 5500 filing — Centrome D/B/A Advanced Biotech Profit Sharing Plan And Trust
Plain-English filing summary
According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20241010155338NAL0010215891001) for Centrome D/B/A Advanced Biotech Profit Sharing Plan And Trust, reported by Centrome, Inc. D/B/A/ Advanced Biotech under EIN 22-3253350 and plan number 001. It reports 124 participants. Attached schedules in the loaded dataset include Schedule H (large plan financials), Schedule C (service provider compensation).
- EFAST2 acknowledgement
- 20241010155338NAL0010215891001
- Filing year
- 2023
- Form type
- 2
- Plan sponsor
- Centrome, Inc. D/B/A/ Advanced Biotech
- EIN
- 22-3253350
- Plan number
- 001
- Location
- Totowa, NJ
- Participants
- 124
- Schedules available
- Schedule H, Schedule C
- Received date
- not reported in the loaded dataset
Reported financial snapshot (2023)
- Total assets (EOY)
- $14,728,156
- Total liabilities (EOY)
- $0
- Net assets (EOY)
- $14,728,156
- Employer contributions
- $757,628
- Participant contributions
- $391,536
- Total income / additions
- $3,047,166
- Benefits paid
- $2,535,708
- Administrative expenses
- $67,184
- Total expenses
- $2,602,892
- Net increase / (decrease)
- $444,274
- Schedule source
- Schedule H
Reported service provider compensation (Schedule C)
| Provider | Service | Direct comp. | Indirect comp. |
|---|---|---|---|
| Merrill Lynch Pierce Fenner & Smith | INVESTMENT ADVISORY | $64,986 | $141 |
| Danziger & Markhoff Llp | OTHER SERVICES | $0 | $5,902 |
| Principal Life Insurance Company | CONTRACT ADMINISTRATOR | $2,200 | $0 |